Résumé
A new H2O2-responsive nanomedicine for CO therapy is constructed by effectively encapsulating the hydrophobic manganese carbonyl prodrug into an advanced hollow mesoporous silica nanoparticle carrier to realize the intratumoral H2O2-triggered release of CO and selective killing of tumour cells rather than normal cells, exhibiting high in vitro and in vivo efficacies of CO therapy.
langue originale | Anglais |
---|---|
Pages (de - à) | 5557-5560 |
Nombre de pages | 4 |
journal | Chemical Communications |
Volume | 53 |
Numéro de publication | 40 |
Les DOIs | |
Etat de la publication | Publié - 1 janv. 2017 |
Modification externe | Oui |